Surveillance for Colorectal Cancer: 99 Real Stories

99 stories match colorectal cancer and surveillance. 86 of them mention surgery.

Mark, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Mark: Stage III Colorectal Cancer

Patient Info: Mark, Male, Under 40 | Stage III

Biomarkers: Lynch syndrome negative

As of March 2025, Mark was sharing his story after surgery and intensive chemotherapy for Stage IIIB colon cancer and had been declared to have no evidence of disease in 2021.

The Patient Story
OutcomeCancer-Free / NED
Edie, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Edie: Stage III Colorectal Cancer

Patient Info: Edie, Female, 50s | Stage III

As of March 2025, Edie had recovered after chemotherapy, radiation, lower anterior resection, temporary ileostomy, and reversal; lymph nodes were negative, margins were clean, and follow-up scans and colonoscopies had remained clear.

The Patient Story
OutcomeCancer-Free / NED
Katie, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Katie's Survivor Story

Patient Info: Katie, Female | Stage III

As of February 2025, Katie had no evidence of disease after surgery and 6 cycles of chemotherapy and was continuing reassuring follow-up, including ctDNA testing.

The Patient Story
OutcomeCancer-Free / NED
Denelle, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Denelle's Survivor Story

Patient Info: Denelle, Female | Stage III

As of February 2025, Denelle had a complete response to total neoadjuvant therapy for Stage IIIB rectal cancer, avoided surgery, and was in active surveillance with scans and scopes every 3 months.

The Patient Story
OutcomeCancer-Free / NED
Jose, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Jose's Survivor Story

Patient Info: Jose Santos, Male, 40s | Stage III

As of December 2024, more than 2 years after surgery for Stage III colorectal cancer, Jose had no evidence of disease, had adapted well to his ileostomy, and no longer had ulcerative colitis symptoms.

City of Hope
OutcomeCancer-Free / NED
Jay, who was diagnosed with Stage I Colorectal CancerColorectal Cancer

Stage I Colorectal Cancer: Jay's Survivor Story

Patient Info: Jay Trevino, Male, 40s | Stage I

As of December 2024, Jay had Stage I colon cancer removed completely by laparoscopic surgery, was home within 24 hours, had a very good prognosis, and was planned for periodic blood tests and CT scans.

Cleveland Clinic
OutcomeCancer-Free / NED
Maddee, who was diagnosed with Stage II Colorectal CancerColorectal Cancer

Stage II Colorectal Cancer: Maddee's Survivor Story

Patient Info: Maddee Moore, Female, Under 40 | Stage II

Biomarkers: Lynch syndrome

As of October 2024, Maddee had no reported recurrence after surgery for Stage II colon cancer and remained in close surveillance because of Lynch syndrome.

The Patient Story
OutcomeCancer-Free / NED
Sophie, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Sophie: Stage IV Colorectal Cancer

Patient Info: Sophie, Female | Stage IV

Biomarkers: BRAF mutation; MSI

Metastatic Site: Liver; lymph nodes; other torso lesions

As of August 2024, Sophie had been declared cancer-free after Stage IV BRAF-mutated/MSI bowel cancer responded to nivolumab/ipilimumab-based immunotherapy, with PET imaging and liver surgery biopsy showing no cancerous cells.

The Patient Story
OutcomeCancer-Free / NED
Andrea, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Andrea's Survivor Story

Patient Info: Andrea, Female, Under 40 | Stage III

As of May 2024, Andrea had completed radiation with continuous 5-FU, 8 intensive chemotherapy infusions, tumor surgery with temporary ileostomy, and ileostomy reversal; a liver-lesion scare was a false alarm and she was cancer-free.

The Patient Story
OutcomeCancer-Free / NED
Savannah, who was diagnosed with Stage II Colorectal CancerColorectal Cancer

Stage II Colorectal Cancer: Savannah's Survivor Story

Patient Info: Savannah Kaspar, Female, Under 40 | Stage II

Biomarkers: Lynch syndrome genetic testing negative

As of March 2024, Savannah had completed partial colectomy and 4 rounds of adjuvant chemotherapy for Stage II sigmoid colon cancer and had entered surveillance with bloodwork every 3 months.

MD Anderson
OutcomeSurvivorship / Surveillance
John, who was diagnosed with Stage II Colorectal CancerColorectal Cancer

Stage II Colorectal Cancer: John's Survivor Story

Patient Info: John, Male, Under 40 | Stage II

As of March 2024, John had a complete response to chemotherapy and radiation for Stage II rectal cancer, with the tumor completely gone, no signs of cancer remaining, no surgery needed, and ongoing watch-and-wait monitoring.

Cleveland Clinic
OutcomeCancer-Free / NED
A patient, who was diagnosed with Colorectal AdenocarcinomaColorectal Cancer

Colon cancer recurrence at a surgical drain site

Patient Info: Anonymized, Male

He recovered well after abdominal-wall excision and was followed every 3–6 months, with no clinical signs of further recurrence or metastasis.

PubMed Central
OutcomeSurvivorship / Surveillance
Jason, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Jason Randall: stage IV colorectal cancer and liver metastases

Patient Info: Jason Randall, Male, Under 40 | Stage IV

Metastatic Site: Liver; lung; tailbone/sacrum/pelvis

As of March 2024, Jason was 2.5 years off chemotherapy and 16 months with no evidence of disease after treatment for Stage IV rectosigmoid colorectal cancer.

City of Hope
OutcomeCancer-Free / NED
Jelena, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Jelena's Survivor Story

Patient Info: Jelena, Female, Under 40 | Stage III

As of January 2024, Jelena was on annual follow-up after Stage III rectal cancer treatment, with her latest colonoscopy showing no polyps or suspicious findings.

The Patient Story
OutcomeCancer-Free / NED
A patient, who was diagnosed with Colorectal Squamous Cell CarcinomaColorectal Cancer

Understanding rectal squamous cell carcinoma, a rare form of rectal cancer

Patient Info: Anonymized, Female

Biomarkers: SCC antigen 0.6 ng/mL at 6-month response assessment

A complete response was established at 6 months, and she remained without clinical, laboratory or imaging evidence of disease 2 years after treatment.

PubMed Central
OutcomeCancer-Free / NED
Jay, who was diagnosed with Stage II Colorectal CancerColorectal Cancer

Stage II Colorectal Cancer: Jay's Survivor Story

Patient Info: Jay McCoy, Male, 40s | Stage II

As of January 2024, Jay had made a full recovery after Stage II colon cancer was found early by colonoscopy and treated surgically, with normal numbers at his second annual physical in June 2023.

Cleveland Clinic
OutcomeSurvivorship / Surveillance
Jim, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Jim's Patient Story

Patient Info: Jim Bromwich, Male, Under 40 | Stage IV

Metastatic Site: Lung

As of January 2024, he had completed focused radiation to an isolated lung nodule and was awaiting follow-up scans; another tiny lung nodule was being monitored but was not PET-avid.

The Patient Story
OutcomeCare Ongoing
Stephanie, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Stephanie's Survivor Story

Patient Info: Stephanie, Female, Under 40 | Stage III

As of November 2023, Stephanie reported that her oncologist said her cancer was in remission after surgery and chemotherapy, with CT/lab follow-up and a PET scan for reassurance.

The Patient Story
OutcomeCancer-Free / NED
Barbara, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Barbara's Survivor Story

Patient Info: Barbara, Female, 40s | Stage III

As of November 2023, Barbara described herself as a colon cancer survivor in year 4 after surgery and chemotherapy, continuing surveillance scans and living with scan anxiety and lasting treatment effects.

The Patient Story
OutcomeSurvivorship / Completed Treatment
Shannon, who was diagnosed with Stage II Colorectal CancerColorectal Cancer

Stage II MSI-High Colorectal Cancer: Shannon's Survivor Story

Patient Info: Shannon, Female, Under 40 | Stage II

Biomarkers: MSI-H; Lynch syndrome; MLH1 mutation

As of October 2023, Shannon had no recurrence described while approaching year 5 after Stage IIA colon cancer surgery and continued intensive Lynch syndrome surveillance.

The Patient Story
OutcomeCancer-Free / NED
Kelly, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III MSI-High Colorectal Cancer: Kelly's Survivor Story

Patient Info: Kelly, Female, Under 40 | Stage III

Biomarkers: dMMR; MSI-H

As of September 2023, Kelly remained in remission after 9 dostarlimab immunotherapy infusions for Stage III dMMR/MSI-H rectal cancer, avoiding the expected chemo/radiation/surgery pathway.

The Patient Story
OutcomeCancer-Free / NED
Amanda, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Amanda's Survivor Story

Patient Info: Amanda Peters, Female, 40s | Stage III

Biomarkers: No genetic markers reported

As of September 2023, Amanda reported no recurrence about 3 years after Stage IIIB rectal cancer surgery and adjuvant chemotherapy, with surveillance CT scans now yearly.

The Patient Story
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Cancer Researcher Becomes Cancer Survivor

Patient Info: J. Mark Brown, Male | Stage III

Ten years after his Stage III colorectal cancer diagnosis, Mark described the treatment as having cured his cancer; he had completed 6 years of periodic oncology follow-up and was living actively with an ileostomy.

Cleveland Clinic
OutcomeCancer-Free / NED
Danielle, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Danielle's Patient Story

Patient Info: Danielle Archer, Female, 40s | Stage IV

Biomarkers: No genetic markers reported

Metastatic Site: Liver; lungs

As of August 2023, Danielle was living with Stage IV metastatic colon cancer involving liver and lung lesions that were stable on ongoing treatment and 3-month surveillance scans.

The Patient Story
OutcomeLiving With Cancer